de Groot Eleanor

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return8%30%16%26%0%
Sale Success Rate1 of 31 of 31 of 31 of 30 of 3

ZIOPHARM Oncology, Inc.

Drugs » Biotechnology

EVP, Operations:

Holdings: 237.11K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--